[go: up one dir, main page]

MX2019005748A - Biomarcadores relacionados a la funcion renal y metodos para usar los mismos. - Google Patents

Biomarcadores relacionados a la funcion renal y metodos para usar los mismos.

Info

Publication number
MX2019005748A
MX2019005748A MX2019005748A MX2019005748A MX2019005748A MX 2019005748 A MX2019005748 A MX 2019005748A MX 2019005748 A MX2019005748 A MX 2019005748A MX 2019005748 A MX2019005748 A MX 2019005748A MX 2019005748 A MX2019005748 A MX 2019005748A
Authority
MX
Mexico
Prior art keywords
methods
biomarkers
renal function
kidney
biomarkers related
Prior art date
Application number
MX2019005748A
Other languages
English (en)
Other versions
MX391220B (es
Inventor
Perichon Regis
V Brown Meredith
Kennedy Adam
Edmond Cobb Jeffery
Original Assignee
Metabolon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolon Inc filed Critical Metabolon Inc
Publication of MX2019005748A publication Critical patent/MX2019005748A/es
Publication of MX391220B publication Critical patent/MX391220B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/64—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving ketones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Se proporcionan biomarcadores de la función renal y métodos para usar los biomarcadores para evaluar la función renal, monitorear la función renal, diagnosticar lesiones renales agudas, y diagnosticar enfermedades renales crónicas. También se proporcionan modalidades de entidades de moléculas pequeñas como biomarcadores para enfermedades renales crónicas.
MX2019005748A 2013-05-14 2014-05-13 Biomarcadores relacionados a la funcion renal y metodos para usar los mismos. MX391220B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361822965P 2013-05-14 2013-05-14
PCT/US2014/037762 WO2014186311A1 (en) 2013-05-14 2014-05-13 Biomarkers related to kidney function and methods using the same

Publications (2)

Publication Number Publication Date
MX2019005748A true MX2019005748A (es) 2019-08-12
MX391220B MX391220B (es) 2025-03-21

Family

ID=51898805

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019005748A MX391220B (es) 2013-05-14 2014-05-13 Biomarcadores relacionados a la funcion renal y metodos para usar los mismos.
MX2015015561A MX365061B (es) 2013-05-14 2014-05-13 Biomarcadores relacionados a la funcion renal y metodos para usar los mismos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2015015561A MX365061B (es) 2013-05-14 2014-05-13 Biomarcadores relacionados a la funcion renal y metodos para usar los mismos.

Country Status (10)

Country Link
US (2) US10539575B2 (es)
EP (3) EP3546940B1 (es)
JP (1) JP6595984B2 (es)
CN (2) CN110196335A (es)
AU (1) AU2014265669B2 (es)
BR (1) BR112015028253A2 (es)
CA (2) CA3184836A1 (es)
ES (2) ES2871823T3 (es)
MX (2) MX391220B (es)
WO (1) WO2014186311A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3546940B1 (en) * 2013-05-14 2021-02-17 Metabolon, Inc. Biomarkers related to kidney function and methods using the same
JP6560200B2 (ja) 2013-10-17 2019-08-14 ザ ジェネラル ホスピタル コーポレイション 自己免疫疾患の治療に応答性の対象を同定する方法およびそれを治療するための組成物
EP3650852B1 (en) * 2015-01-09 2021-08-18 Global Genomics Group, LLC Blood based biomarkers for diagnosing atherosclerotic coronary artery disease
WO2016115496A1 (en) * 2015-01-15 2016-07-21 Joslin Diabetes Center Metabolite biomarkers predictive of renal disease in diabetic patients
WO2017059132A1 (en) * 2015-09-29 2017-04-06 The General Hospital Corporation Methods of treating and diagnosing disease using biomarkers for bcg therapy
US20170234874A1 (en) * 2015-10-07 2017-08-17 Clearbridge Biophotonics Pte Ltd. Integrated visual morphology and cell protein expression using resonance-light scattering
US12057228B1 (en) * 2015-12-30 2024-08-06 Cerner Innovation, Inc. Predicting newly incident chronic kidney disease
WO2018022866A1 (en) 2016-07-28 2018-02-01 Metabolon, Inc. Diagnostic methods, therapeutic agents and uses thereof
DK3552022T3 (da) * 2016-11-25 2021-08-23 Implexion AB Metaboliske lidelser
US11619636B2 (en) 2016-12-19 2023-04-04 Metabolon, Inc. Mass spectrometry assay method for detection and quantitation of kidney function metabolites
CN108956790A (zh) * 2017-05-18 2018-12-07 中国人民解放军第二军医大学第二附属医院 一组氨基酸标志物在急性肾损伤诊断试剂盒中的应用
CN107132266A (zh) * 2017-06-21 2017-09-05 佛山科学技术学院 一种基于随机森林的水质分类方法及系统
US11026625B2 (en) 2017-08-08 2021-06-08 Fresenius Medical Care Holdings, Inc. Systems and methods for treating and estimating progression of chronic kidney disease
CN107326093B (zh) * 2017-09-04 2020-01-21 东南大学 基于Taqman探针的慢性肾脏病相关基因检测荧光定量PCR一步法试剂盒及其应用
WO2019067699A1 (en) * 2017-09-28 2019-04-04 Metabolon, Inc. COMPOUNDS, REAGENTS AND USES THEREOF
ES2953127T3 (es) * 2018-01-19 2023-11-08 Mars Inc Biomarcadores y algoritmos de clasificación para enfermedad renal crónica en gatos
EP3821254A1 (en) * 2018-07-14 2021-05-19 Mars Incorporated Biomarkers and test models for chronic kidney disease
CN113454462A (zh) * 2019-02-20 2021-09-28 株式会社合伙企业 固相反应芯片和使用该固相反应芯片的测定方法
CN112305089B (zh) * 2019-07-26 2022-04-29 长沙都正生物科技股份有限公司 一种慢性肾病诊断生物标记物及其应用
EP4004541A1 (en) * 2019-07-26 2022-06-01 Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Ergothioneine, s-methyl-ergothioneine, and uses thereof
CN111487338B (zh) * 2020-04-16 2022-06-10 中南大学湘雅二医院 一种与肾功能相关的无创生物标记物及其应用
WO2021232211A1 (zh) * 2020-05-19 2021-11-25 深圳市中医院 诊断肾病的标志物以及诊断方法
CN114910587B (zh) * 2022-05-12 2024-03-19 军科正源(上海)生物医药科技有限公司 一种尿液检测用高效液相-串联质谱分析方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02196787A (ja) * 1989-01-25 1990-08-03 Otsuka Pharmaceut Co Ltd シュードウリジン誘導体
JPH0661278B2 (ja) * 1990-09-18 1994-08-17 旭化成工業株式会社 ミオイノシトールの高感度定量法および定量用組成物
US5712084A (en) * 1995-09-08 1998-01-27 Research Corporation Technologies, Inc. Donor kidney viability test for improved preservation
CN101377492B (zh) 2007-08-29 2014-04-23 北京九强生物技术股份有限公司 胱抑素c测定试剂盒
JP5947544B2 (ja) * 2008-08-29 2016-07-06 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後のための方法および組成物
US9421330B2 (en) 2008-11-03 2016-08-23 Bayer Healthcare Llc Mitigation of contrast-induced nephropathy
CN104034901A (zh) * 2008-11-22 2014-09-10 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
WO2010124269A1 (en) * 2009-04-24 2010-10-28 National Center For Genome Resources Methods for diagnosis of sepsis and risk of death
JP5197846B2 (ja) 2009-04-30 2013-05-15 紀陽 田仲 腎疾患重篤度を判定する方法又は装置若しくはその作動方法
CN102458418B (zh) * 2009-06-08 2015-09-16 夸克制药公司 一种寡核苷酸化合物的制药用途
US8709816B2 (en) 2009-09-04 2014-04-29 Tohoku University Human renal disease marker substance
CN102725636B (zh) * 2009-12-20 2015-04-01 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
US8980548B2 (en) 2010-05-19 2015-03-17 Metabolon, Inc. Methods and reagents for metabolomics and histology in a biological sample and a kit for the same
US9465039B2 (en) * 2010-08-06 2016-10-11 Mycartis Nv Perlecan as a biomarker for renal dysfunction
JP5916058B2 (ja) * 2011-08-26 2016-05-11 国立大学法人東北大学 細胞ストレス状態のバイオマーカー
KR20140074293A (ko) * 2011-09-14 2014-06-17 바스프 에스이 신장 독성을 평가하기 위한 수단 및 방법
WO2013048344A1 (en) * 2011-09-29 2013-04-04 National University Of Singapore Urinary metabolomic markers for renal insufficiency
EP3546940B1 (en) * 2013-05-14 2021-02-17 Metabolon, Inc. Biomarkers related to kidney function and methods using the same
WO2018022866A1 (en) * 2016-07-28 2018-02-01 Metabolon, Inc. Diagnostic methods, therapeutic agents and uses thereof

Also Published As

Publication number Publication date
MX2015015561A (es) 2016-02-05
CN105209909B (zh) 2019-06-07
CA2911204C (en) 2023-03-28
CN110196335A (zh) 2019-09-03
AU2014265669B2 (en) 2020-05-14
HK1218331A1 (zh) 2017-02-10
EP2997366B1 (en) 2018-10-10
BR112015028253A2 (pt) 2017-07-25
CN105209909A (zh) 2015-12-30
EP2997366A1 (en) 2016-03-23
EP3546940B1 (en) 2021-02-17
EP2997366A4 (en) 2017-04-12
EP3546940A1 (en) 2019-10-02
JP2016520192A (ja) 2016-07-11
ES2871823T3 (es) 2021-11-02
EP3410115A1 (en) 2018-12-05
CA2911204A1 (en) 2014-11-20
US20200103417A1 (en) 2020-04-02
JP6595984B2 (ja) 2019-10-23
US10539575B2 (en) 2020-01-21
CA3184836A1 (en) 2014-11-20
ES2702123T3 (es) 2019-02-27
MX365061B (es) 2019-05-22
HK1222905A1 (en) 2017-07-14
AU2014265669A1 (en) 2015-12-24
WO2014186311A1 (en) 2014-11-20
US20160116486A1 (en) 2016-04-28
MX391220B (es) 2025-03-21

Similar Documents

Publication Publication Date Title
MX2019005748A (es) Biomarcadores relacionados a la funcion renal y metodos para usar los mismos.
EP3084419C0 (en) ADVANCED ULTRASONIC INSPECTION
EP3074575C0 (en) MONITORING WEARING PARTS
EP2967361A4 (en) KIDNEY PUMP
EP2968749A4 (en) DOUBLE-ACTING INFUSION SYSTEM
MX2017007941A (es) Anticuerpos antagonistas anti-axl.
HUE045723T2 (hu) Módszerek vesebetegség kimutatására
ES1106132Y (es) LLave universal
FR3003076B1 (fr) Supercondensateur electrochimique
CL2016001147A1 (es) Anticuerpos específicos para fcrn.
DK3013796T3 (da) Biarylderivater som gpr120-agonister
PT3192922T (pt) Óleo para fibra acrílica precursora de fibra de carbono, composição de óleo para fibra acrílica precursora de fibra de carbono, líquido de tratamento de óleo para fibra acrílica precursora de fibra de carbono e feixe de fibras acrílicas precursoras de fibras de carbono
ES1102507Y (es) Util desechable para orinar.
EP2938417A4 (en) DOUBLE DOUBLE FILTER INTEGRITY inspection system
EP2969412A4 (en) LUBRICATING DEVICE FOR A ROTATING KNIFE
PT2972368T (pt) Biomarcadores linfocitários para determinação de resposta clínica a terapia celular
EP2943343A4 (en) CONTAINER WITH ONE EDGE WITH VARIABLE RADIUS
AR094118A1 (es) Lesion renal aguda
CL2016000447A1 (es) Marcadores de riesgo para cardiovasculopatías en pacientes con nefropatía crónica.
EP2916913A4 (en) HIGHLY POROUS CELLULOSIC SPONGE
DE112014005613A5 (de) Doppelkupplung
ES1098006Y (es) Unidad de acoplamiento para mangueras.
DE112014005678A5 (de) Doppelkupplung
CL2012001792A1 (es) Procedimiento para establecer automaticamente una relacion entre unos datos semanticos y la ejecucion de un widget empleando los datos semanticos como parametros de entrada de ejecucion del widget.
ES1078670Y (es) Suela para calzados tipo chancleta con atenuación del sonido de marcha